Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease

ClinicalTrials.gov ID: NCT00322153

Public ClinicalTrials.gov record NCT00322153. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 3:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Memantine in Patients With Moderate-to-Severe Dementia of the Alzheimer's Type

Study identification

NCT ID
NCT00322153
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Forest Laboratories
Industry
Enrollment
677 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • memantine ER Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2005
Primary completion
Sep 30, 2007
Completion
Dec 31, 2007
Last update posted
Sep 15, 2010

2005 – 2008

United States locations

U.S. sites
38
U.S. states
17
U.S. cities
37
Facility City State ZIP Site status
Forest Investigative Site 010 Phoenix Arizona 85004
Forest Investigative Site 062 Costa Mesa California 92626
Forest Investigative Site 050 Fresno California 93720
Forest Investigative Site 024 San Francisco California 94118
Forest Investigative Site 071 Santa Ana California 92705
Forest Investigative Site 002 Denver Colorado 80262
Forest Investigative Site 021 Boca Raton Florida 33486
Forest Investigative Site 052 Boynton Beach Florida 33426
Forest Investigative Site 070 Delray Beach Florida 33445
Forest Investigative Site 065 Fort Myers Florida 33912
Forest Investigative Site 043 Hallandale Florida 33009
Forest Investigative Site 044 Hallandale Florida 33009
Forest Investigative Site 001 Miami Florida 33137
Forest Investigative Site 034 North Miami Florida 33161
Forest Investigative Site 068 Orlando Florida 32806
Forest Investigative Site 038 Palm Beach Gardens Florida 33410
Forest Investigative Site 008 St. Petersburg Florida 33709
Forest Investigative Site 028 Tampa Florida 33617
Forest Investigative Site 009 Snellville Georgia 30078
Forest Investigative Site 069 Joliet Illinois 60435
Forest Investigative Site 045 Kalamazoo Michigan 49048
Forest Investigative Site 014 Saint Loius Missouri 63104
Forest Investigative Site 064 Long Branch New Jersey 07742
Forest Investigative Site 011 Morristown New Jersey 07960
Forest Investigative Site 003 New Brunswick New Jersey 08903
Forest Investigative Site 048 Albany New York 12205
Forest Investigative Site 006 Buffalo New York 14215
Forest Investigative Site 004 White Plains New York 10605
Forest Investigative Site 027 Centerville Ohio 45459
Forest Investigative Site 012 Toledo Ohio 43623
Forest Investigative Site 020 Portland Oregon 97210
Forest Investigative Site 032 Greensburg Pennsylvania 15601
Forest Investigative Site 018 Jenkintown Pennsylvania 19046
Forest Investigative Site 067 East Providence Rhode Island 02914
Forest Investigative Site 041 Austin Texas 78757
Forest Investigative Site 017 San Antonio Texas 78229
Forest Investigative Site 013 Richmond Virginia 23229
Forest Investigative Site 026 Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00322153, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 15, 2010 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00322153 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →